Investor Alert: Deadline Approaching to Join Lantheus Holdings, Inc. (LNTH) Class Action – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / October 23, 2025 / If you suffered a loss on your Lantheus Holdings, Inc. (NASDAQ:LNTH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lantheus-holdings-inc-lawsuit-submission-form-2?prid=173550&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

Minesto part of InnoEnergy’s The Business Booster in Lisbon

Leading ocean energy developer Minesto is selected to be part of InnoEnergy's annual industry event The Business Booster, this year in Lisbon, Portugal 22-23 October 2025. InnoEnergy, initiated by the European Institute of Innovation and Technology (EIT), is Europe's investment company at the forefront of clean energy transition. InnoEnergy's The Business Booster gathers the most

JEF Investors Have Opportunity to Join Jefferies Financial Group Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofJefferies Financial Group Inc. (“Jefferies” or “the Company”) (NYSE: JEF) for violations of the securities laws. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent

MoonLake Immunotherapeutics Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX

The DJS Law Group reminds investors of a class action lawsuit against MoonLake Immunotherapeutics (“MoonLake ” or “the Company”) (NASDAQ: MLTX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MLTX during the

FLR Investors Have Opportunity to Join Fluor Corporation Fraud Investigation With the DJS Law Group

The DJS Law Group reminds investors that it is investigating claims against Fluor Corporation (“Fluor” or “the Company”) (NYSE: FLR) for violations of securities laws. The investigation centers on whether the Company made false and/or misleading statements or omitted information critical to investors. On August 1, 2025, Fluor announced its second-quarter financial results and reduced

CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstCytokinetics, Incorporated (“Cytokinetics” or “the Company”) (NASDAQ: CYTK) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the Company's

Lantheus Holdings, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – LNTH

The DJS Law Group reminds investors of a class action lawsuit against Lantheus Holdings, Inc. (“Lantheus ” or “the Company”) (NASDAQ: LNTH ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of LNTH during

[Latest] Global Radiopharmaceutical CDMO Market Size/Share Worth USD 7.2 Billion by 2034 at a 9.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Oct. 23, 2025 (GLOBE NEWSWIRE) — Custom Market Insights has published a new research report titled “Radiopharmaceutical CDMO Market Size, Trends and Insights By Application (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals), By Radioisotope Type (Technetium-99m, Fluorine-18, Lutetium-177, Gallium-68, Actinium-225, Others), By Source of Manufacturing (Nuclear Reactors, Cyclotrons), By Therapeutic Area (Oncology, Neurological Disorders, Cardiovascular

Scroll to Top